This site is for US consumers.This site is for US consumers.

COVID-19 isn't giving up, so our vaccine has been updated.*

Moderna COVID-19 Vaccine (2024-2025 Formula) is authorized for use in children 6 months through 11 years of age.

* Update is consistent with VRBPAC guidance.

Report adverse event

Authorized Use

Moderna COVID-19 Vaccine (2024-2025 Formula) has not been approved or licensed by the FDA, but has been authorized by the FDA, under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) in individuals 6 months through 11 years of age.

The EUA for this product is in effect for the duration of the COVID-19 EUA declaration justifying emergency use of the product, unless the declaration is terminated or the authorization is revoked sooner.

For more information on the EUA authorized uses of the vaccine, refer to the Fact Sheet for Healthcare Providers Administering Vaccine.


Resources

Fact Sheet for Recipients

Read now

Fact Sheet for Providers

Letter of Authorization


We're here to help!

Please contact us if you have any questions about ordering and product availability or to arrange an appointment with our field staff.

Email

[email protected]

Phone

1-866-MODERNA (1-866-663-3762)

8:00 AM - 8:00 PM ET

Monday - Friday (closed holidays)

Important Safety Information

What should you mention to the vaccination provider before your child gets Moderna COVID-19 Vaccine (2024-2025 Formula)?

Tell the vaccination provider about all your child’s medical conditions, including if your child:

  • has any allergies
  • has had myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of the lining outside the heart)
  • has a fever
  • has a bleeding disorder or is on a blood thinner
  • is immunocompromised or is on a medicine that affects your child's immune system
  • is pregnant
  • is breastfeeding
  • has received any other COVID-19 vaccine
  • has ever fainted in association with an injection
Who should not get Moderna COVID-19 Vaccine (2024-2025 Formula)?

Your child should not get Moderna COVID-19 Vaccine if your child had:

  • a severe allergic reaction after a previous dose of any Moderna COVID-19 Vaccine
  • a severe allergic reaction to any ingredient in these vaccines
What are the risks of Moderna COVID-19 Vaccine (2024-2025 Formula)?

Severe allergic reactions: there is a remote chance that the vaccine could cause a severe allergic reaction. A severe allergic reaction would usually happen within a few minutes to one hour after getting a dose. Signs of a severe allergic reaction can include:

  • Difficulty breathing
  • Swelling of the face and throat
  • A fast heartbeat
  • A bad rash all over the body
  • Dizziness and weakness

Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining outside the heart) have happened in some people who have received mRNA COVID-19 vaccines. Myocarditis and pericarditis following Moderna COVID-19 vaccines have occurred most commonly in young adult males 18 years through 24 years of age. In most of these individuals, symptoms began within a few days following vaccination. The chance of having this occur is very low. Seek medical attention right away if your child has any of the following symptoms after receiving the vaccine, particularly during the 2 weeks after your child receives a dose:

  • Chest pain
  • Shortness of breath or difficulty breathing
  • Feelings of having a fast-beating, fluttering, or pounding heart

Additional symptoms, particularly in children, may include:

  • Fainting
  • Unusual and persistent irritability
  • Unusual and persistent poor feeding
  • Unusual and persistent fatigue or lack of energy
  • Persistent vomiting
  • Persistent pain in the abdomen
  • Unusual and persistent cool, pale skin

Side effects that have been reported in clinical trials with Moderna COVID-19 vaccines include:

  • Injection site reactions: pain, tenderness and swelling of the lymph nodes in the same arm of the injection or in the groin, swelling (hardness), and redness
  • General side effects: fatigue, headache, muscle pain, joint pain, chills, nausea and vomiting, fever, rash, irritability/crying, sleepiness, and loss of appetite

Side effects that have been reported during post-authorization use include:

  • Severe allergic reactions
  • Urticaria (itchy rash/hives)
  • Myocarditis (inflammation of the heart muscle)
  • Pericarditis (inflammation of the lining outside the heart)
  • Fainting in association with injection of the vaccine
  • Febrile seizures (convulsions during a fever)

These may not be all the possible side effects. Serious and unexpected side effects may occur. The possible side effects are still being studied.

What should I do about side effects?

If your child experiences a severe allergic reaction, call 9-1-1, or go to the nearest hospital.

Call the vaccination provider or your child's healthcare provider if your child has any side effects that bother your child or do not go away.

Report vaccine side effects to FDA/CDC Vaccine Adverse Event Reporting System (VAERS). The VAERS toll-free number is 1-800-822-7967 or report online to https://vaers.hhs.gov/reportevent.html. Please include “Moderna COVID-19 (2023-2024 Formula) EUA” in the first line of box #18 of the report form.

In addition, you can report side effects to ModernaTX, Inc. at 1-866-MODERNA (1-866-663-3762). Please see the Moderna COVID-19 Vaccine (2024-2025 Formula) Fact Sheet for Recipients and Caregivers for more information.

Stay up to date

Receive the latest information about all products from Moderna.

By submitting your information, you agree to Moderna's Terms and Conditions. You also acknowledge that your information will be processed in accordance with Moderna's Privacy Statement. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.


Helpful Links
Visit the Healthcare Professional site
About Moderna
Connect with Us
Report a side effect:
Adverse Event Intake Portal
Terms and conditionsPrivacy statement

© 2024 Moderna US-COV-2400031 08/2024